Is Aventyl Hydrochloride still available?

Aventyl Hydrochloride (NDA 014684) is listed as Discontinued in the FDA Orange Book — it is no longer marketed. A discontinued status is not, by itself, a determination that the drug was withdrawn for safety or effectiveness.

What is Aventyl Hydrochloride's FDA application number?

Aventyl Hydrochloride is approved under NDA 014684, held by Lilly.

Orange Book product · Brand (NDA)

Aventyl Hydrochloride

Nortriptyline Hydrochloride

Brand (NDA)NDA 014684Discontinued Lilly

Approved

Approved Prior to Jan 1, 1982

Application

Brand (NDA)

TE code

Not listed

Listed patents

Aventyl Hydrochloride (Nortriptyline Hydrochloride) is Lilly's brand-name drug, approved by the FDA under NDA 014684. Its marketing status is listed as discontinued; a discontinued listing is not, by itself, a finding that the drug was withdrawn for safety or effectiveness. 11 approved generics share this drug's active ingredient.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

No patent or exclusivity dates are listed for this product.

FDA product record

Pharmaceutical detail

Active ingredient

NORTRIPTYLINE HYDROCHLORIDE

Strength

EQ 25MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 014684

Product number

002

Marketing status

Discontinued

Reference listed drug (RLD)

Reference standard (RS)

Same application

Other strengths in NDA 014684

EQ 10MG BASECAPSULE

Brand + generics

Active-ingredient family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

View full Nortriptyline Hydrochloride family

Orange Book patent file

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.